93 results
Page 4 of 5
8-K
EX-99.1
p9wou14 x87zz3xmcuf
13 Jan 20
Magenta Therapeutics Advances Conditioning Platform and Clinical Programs, Highlights Recent Milestones and 2020 Goals
8:16am
8-K
a9wwz 7hf0sc3b
13 Jan 20
Magenta Therapeutics Advances Conditioning Platform and Clinical Programs, Highlights Recent Milestones and 2020 Goals
8:16am
424B5
w3bepvmx
21 Aug 19
Prospectus supplement for primary offering
4:37pm
UPLOAD
6dyivyoy
12 Aug 19
Letter from SEC
12:00am
S-3
vh2bzhsnuu8zc 946wr7
8 Aug 19
Shelf registration
4:16pm
S-3
EX-1.2
bs6jqi 8j4m9b74i
8 Aug 19
Shelf registration
4:16pm
8-K
EX-99.1
vvgx fk5alnjsj
8 Aug 19
Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
8:13am
8-K
3jg5 ka7uu
24 Jun 19
Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
4:48pm
8-K
EX-99.1
at4d2s
24 Jun 19
Magenta Therapeutics Appoints Anne McGeorge to Board of Directors
4:48pm
424B4
ly50fifu fodu
2 May 19
Prospectus supplement with pricing info
4:12pm
DEF 14A
i1zld29nf
25 Apr 19
Definitive proxy
4:26pm
UPLOAD
85apyo57
4 Apr 19
Letter from SEC
12:00am
DRS
bwmhk60u80qsowt3n8
29 Mar 19
Draft registration statement
12:00am
10-K
zjuecpveycmz7p87m0
19 Mar 19
Annual report
7:44am
8-K
9kgmr7wvn1854qsab
7 Jan 19
Regulation FD Disclosure
7:30am